A carregar...
MGMT promoter methylation in serum and cerebrospinal fluid as a tumor-specific biomarker of glioma
O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation is a conventional technique to predict the prognosis or individualized treatment of glioma in tumor tissue following surgery or biopsy. However, the technique cannot be applied in those glioma patients with concomitant neurological...
Na minha lista:
| Publicado no: | Biomed Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4487030/ https://ncbi.nlm.nih.gov/pubmed/26171163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2015.462 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|